Why the study?
Does physiological IGF-1 plus insulin enhance the differentiation of rat mesenteric-stromal vascular cells into adipocytes?
Does physiological IGF-1 plus insulin enhance the differentiation of rat mesenteric-stromal vascular cells into adipocytes?
Physiological levels of insulin and IGF-1 synergistically enhance the differentiation of rat mesenteric-stromal vascular cells into visceral adipocytes, providing a relevant in vitro model for metabolic syndrome research.
Should not change clinical practice; hypothesis-generating for IGF-1/insulin synergy in visceral adipocyte models.
Visceral adipose tissue, particularly mesenteric adipose tissue, is important in the pathogenesis of metabolic syndrome. Here, we present a physiologically relevant differentiation system of rat mesenteric-stromal vascular cells (mSVC) to mesenteric-visceral adipocytes (mVAC). We optimized the insulin concentration at levels comparable to those in vivo ( approximately 0.85 ng/ml) by including physiological concentrations of IGF-1. We found that the insulin-like growth factor (IGF-1) and insulin worked synergistically, since IGF-1 alone could induce CCAAT/enhancer binding protein alpha (C/EBPalpha) and adipocyte lipid binding protein (aP2) mRNA expression but not lipid droplet accumulation associated with maturation. Using real-time PCR analyses on 180 adipocyte-related genes, we identified a dramatic effect by IGF-1 plus insulin. We also demonstrated the state of insulin resistance at pathologically high insulin concentrations. This culture system will contribute to understanding the physiological differentiation process and the patho/physiology of mVAC.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: